News | Defibrillator Monitors | April 24, 2020

FDA Lifts Injunction on Philips Defibrillators

Injunction on Philips AEDs has been in place since November 2017

 

 

The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and shipping of external defibrillator AEDs in the United States. 

April 24, 2020 — The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and shipping of external defibrillators for the United States. 

Royal Philips said its emergency care and resuscitation (ECR) business has been operating under a consent decree with the FDA since November 2017. Under the terms of the consent decree, Philips was required to suspend manufacture and distribution of its defibrillators from specific Philips facilities in the U.S., pending FDA certification via inspection of the facilities’ compliance with Quality System Regulation. However, in order to ensure uninterrupted availability of these life-saving devices in the U.S., the consent decree included exemptions for specific Philips automated external defribrillator (AED) models to continue to be manufactured and shipped, in addition to providing necessary device servicing, accessories and consumables.

Philips continues to comply with the terms of the consent decree, which remains in effect, and includes ongoing regulatory compliance monitoring and facility inspections of the ECR business and of Philips’ other patient care businesses by the FDA.

“The injunction lift is an important milestone for Philips, as we have enhanced the regulatory compliance processes in our ECR business and throughout the company,” said Frans van Houten, CEO of Royal Philips. “Providing our customers with safe and reliable products and solutions remains our highest priority, and I am proud that our AEDs save lives daily, with their very high reliability record.”

For more information: https://www.usa.philips.com/healthcare/solutions/emergency-care-resuscitation/automated-external-defibrillators

Related Content

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

News | Defibrillator Monitors | June 23, 2020
June 23, 2020 — Philips announced the U.S.
tryker is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.

tryker is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.

News | Defibrillator Monitors | January 13, 2020
January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 ...
Philips Receives FDA PMA for HeartStart OnSite and HeartStart Home Defibrillators

The Philips HeartStart OnSite automated external defibrillator. Image courtesy of Philips Healthcare.

Technology | Defibrillator Monitors | June 19, 2019
Philips announced the U.S. Food and Drug Administration (FDA) has approved the company’s premarket approval (PMA)...
HeartHero Personal Automated External Defibrillator Wins ACC.19 Innovation Challenge
News | Defibrillator Monitors | April 05, 2019
April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the...
Stryker has recalled its LifePak 15 defibrillator-monitor system because it may lock up after delivering a shock to a patient. The defibrillator was originally made by Physio-Control, before being purchased by Stryker.

Stryker has initiated a field action to prevent its LifePak 15 defibrillator-monitor systems from locking up after delivering a shock to a patient. 

Feature | Defibrillator Monitors | February 04, 2019
February 4, 2019 — Stryker announced Feb.
The Zoll LifeVest wearable defibrillator was the subject of the VEST Trial

The Zoll LifeVest wearable defibrillator system was evaluated in the late-breaking VEST Trial presented at ACC 2018 earlier this year.

Feature | Defibrillator Monitors | July 10, 2018 | Michael J. Mirro, M.D.
Following the...
Rice University Students Improve AED Operation With Needle Pad

The automated external defibrillator add-on developed by Rice University students is a pad of needles that break through the skin's natural impedance barrier to deliver an electric shock to the heart of a patient in cardiac arrest. (Credit: Jeff Fitlow/Rice University)

News | Defibrillator Monitors | April 16, 2018
The skin presents a formidable barrier to life-saving defibrillators, but a team of students from Rice University...
Zoll Canada Equipping Province of Québec Paramedic Services with X Series Monitor/Defibrillators
News | Defibrillator Monitors | October 16, 2017
October 16, 2017 — Zoll Canada, a subsidiary of Zoll Medical Corp., announced it has won the tender to equip all ambu
Physio-Control Launches HeartSine samaritan PAD 360P Automated External Defibrillator in United States
Technology | Defibrillator Monitors | April 24, 2017
Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully automatic external...